Back

Prevalence of heart failure patients in the Czech Republic. A population-based study

13 May 2024 (15:40 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome 8 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Jiri Parenica

FNUSA, Brno (Czechia)

5 More presentations in this session

Presentation thumbnail
Post-discharge therapeutic compliance of patients with heart failure: telephonic follow-up within 6 months.
Associate Professor S. Vetrila (Chisinau, MD)
Abstract Slides Video
Presentation thumbnail
The effect of gender on prognosis in patients with sinus rhythm and in patients with atrial fibrillation in heart failure with reduced ejection fraction
Associate Professor G. Kozdag Gold (Bronx, US)
Abstract Slides Video
Presentation thumbnail
Epidemiological, clinical, paraclinical, evolutionary and therapeutic aspects of hypertensive patients infected with COVID-19
Doctor A. Ngaide (Dakar, SN)
Abstract Slides Video
Presentation thumbnail
Predictors of adverse cardiovascular events in patients with heart failure: insights from a real-world population followed in a regional hospital in portugal
Doctor A. Fonseca Vazao (Leiria, PT)
Abstract Slides Video
Presentation thumbnail
Erectile dysfunction as negative predictor of left ventricular diastolic dysfunction
Doctor N. Sabanovic-Bajramovic (Sarajevo, BA)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome 8

The Event

Event poster

Heart Failure 2024

13 May 2024 15:40 CET
You may be interested in
thumbnail
Congress Presentation
Epidemiology of heart failure
thumbnail
Congress Presentation
Epidemiological insights into heart failure: prevalence, incidence, and mortality rates in the population of Slovakia
thumbnail
Congress Presentation
Prevalence and incidence of heart failure in Hungary stratified by age and sex: data from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources